<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16635">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01908309</url>
  </required_header>
  <id_info>
    <org_study_id>K-3</org_study_id>
    <nct_id>NCT01908309</nct_id>
  </id_info>
  <brief_title>Contrast-inDuced nephRotoxicity as Assessed by the KIdney Load-to-DAmage RElationship</brief_title>
  <acronym>DrKILDARE</acronym>
  <official_title>Contrast-inDuced nephRotoxicity as Assessed by the Cystatin-modified KIdney Load-to-DAmage RElationship</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Sanitaria Locale  9,  Grosseto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Sanitaria Locale  9,  Grosseto</source>
  <oversight_info>
    <authority>Italy: National Monitoring Centre for Clinical Trials - Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We previously demonstrated that the slope of the relationship plotting individual iodine
      loads against contrast-induced serum creatinine changes ( the load-to-damage relationship,
      LDR) characterizes the intrinsic nephrotoxicity of the contrast. Aim of the present study is
      to compare, through the assessment of the LDR slope,  the intrinsic nephrotoxicity of two
      different contrast media using serum cystatin-C changes as the LDR dependent variable.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We previously demonstrated that the slope of the relationship plotting individual iodine
      loads against contrast-induced serum creatinine changes ( the load-to-damage relationship,
      LDR) characterizes the intrinsic nephrotoxicity of the contrast and it may allow for
      reliable comparative evaluations among small sized study groups randomized to different
      contrast media. The aim of the present study is to compare, through the assessment of the
      LDR slope,  the intrinsic nephrotoxicity of two different contrast media using serum
      cystatin-C changes as the LDR dependent variable.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Slope of LDR (as assessed by serum cystatin-C changes)</measure>
    <time_frame>48 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Slope of the relationship plotting individual iodine loads against serum cystatin-C changes at 48 hours after catheterization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Slope of LDR (as assessed by serum creatinine changes)</measure>
    <time_frame>72 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Slope of the relationship plotting individual iodine loads against serum creatinine changes at 72 hours after catheterization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Contrast Induced Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Iodixanol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to coronary angiography/angioplasty with Iodixanol 320</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iobitridol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to coronary angiography/angioplasty with Iobitridol 350</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iobitridol 350</intervention_name>
    <arm_group_label>Iobitridol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iodixanol 320</intervention_name>
    <arm_group_label>Iodixanol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients candidate to coronary angiography and/or angioplasty and

          -  Baseline creatinine clearance &lt; 60 ml/min

        Exclusion Criteria:

          -  Patients with STEMI

          -  Patients with shock

          -  Known allergy to contrast media

          -  Prior contrast administration within 1 month

          -  Current use of nonsteroidal anti-inflammatory drugs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ugo Limbruno, MD, Phd</last_name>
    <phone>+393346998150</phone>
    <email>u.limbruno@usl9.toscana.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Misericordia Hospital, ASL 9</name>
      <address>
        <city>Grosseto</city>
        <zip>58100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ugo Limbruno, MD, PhD</last_name>
      <phone>+393346998150</phone>
      <email>u.limbruno@usl9.toscana.it</email>
    </contact>
    <investigator>
      <last_name>Ugo Limbruno, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Picchi, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paolo Calabria, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Limbruno U, Picchi A, Micheli A, Calabria P, Cortese B, Brizi G, Severi S, De Caterina R. Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship. J Cardiovasc Med (Hagerstown). 2013 Jun 27. [Epub ahead of print]</citation>
    <PMID>23811842</PMID>
  </reference>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 24, 2013</lastchanged_date>
  <firstreceived_date>July 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Sanitaria Locale  9,  Grosseto</investigator_affiliation>
    <investigator_full_name>Ugo Limbruno</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>acute kidney injury</keyword>
  <keyword>contrast media</keyword>
  <keyword>cystatin-C</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cystatins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
